20. Commercial package deals and alleged inducements to prescribe
Rina & Jean cover the recent ruling in Case AUTH/3701/10/22 (Astellas v Janssen) and discuss pharma providing nurse support, patient support programmes and inducements to individuals.
26 Loka 20232min
19. Comms fit for the public - learn from Virginia Chachati, Pharmacist & Clinical Content Creator
When it comes to pharma materials, we know our intent vs the impression to readers can be different! This can lead to: not getting the right message across difficulty getting engagement from the r...
19 Loka 202314min
18. Disease Awareness - Part 1
The topic of Disease Awareness always produces a lot of questions. We tackle some of them in this podcast. The case mentioned is case AUTH/3652/5/22.
12 Loka 20235min
17. Cocktails in a 5-star hotel
Rina & Jean chat about how the venue and signage for UK pharma meetings can give a misleading impression. Case discussed is Case AUTH/3644/5/22 & AUTH/3694/10/22.
5 Loka 20236min
16. When and how to use patient case studies
Patient case studies can be used really well in a variety of ways by different functions within pharma. Case mentioned is Case AUTH/3503/4/21. Further information in this article: https://globalforum...
28 Syys 20236min
14. Engaging patients to provide a service
Who, why, when and how should UK pharma compliantly engage patients to provide a range of services? We provide clarity in just a few minutes.
21 Syys 20236min
15. Should/could medical education mention medicine?
Rina & Jean discuss why and how medical education could mention medicine - the pros and the cons, mentioning the results of a LinkedIn poll and Case AUTH/3244/9/19.
21 Syys 20235min
13. Can I buy a Dr a coffee?
How should we handle questions like this? Say no (there could be cake involved!!!)? Or say yes? Which questions should we be asking to be helpful, constructive and compliant?
14 Syys 20236min
